Trials / Completed
CompletedNCT00002366
The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
A Phase II Safety and Activity Study of Ritonavir in the Treatment of HIV-Associated Cutaneous Kaposi's Sarcoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and anti-Kaposi's sarcoma activity of ritonavir.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ritonavir |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2009-02-20
Locations
2 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT00002366. Inclusion in this directory is not an endorsement.